PPT-Update on Prevention of COPD Exacerbations

Introduction Susceptibility to Exacerbation in COPD Lung Function Impairment COPD Hospitalizations and Mortality LongTerm Natural History of COPD Bronchoscopic Validation of the Significance of Sputum Purulence in Severe Exacerbations of COPD. COPD is characterized by :. **Chronic airflow obstruction & accelerated . . loss of lung function which is progressive & . NOT. fully reversible.. ** COPD is preventable & treatable but . Obstructive Pulmonary Disease . & Chronic . Bronchitis. DR.S.H.HASHEMI. 1. COPD . ranked as the . fourth. . leading cause of death in 2000.. Dual LAMA/LABA Bronchodilation in COPD Therapy in Light of . New Clinical Data?. Program Overview. Managing Stable COPD: Goals of Therapy. Updated GOLD Recommendations: . First-line Pharmacologic Therapy for Stable COPD. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. Key points. An exacerbation of chronic obstructive pulmonary disease is defined as an acute deterioration of respiratory symptoms that needs medical attention and may need a change in regular treatment. Clinical Research Fellow. University of Oxford. Acute Exacerbations of COPD. Introduction . Epidemiology. Causes. How to know who’s exacerbating. When to use antibiotics. When to use corticosteroids. Julia Rogers, MSN, RN, CNS, FNP-BC. Diagnosis and Overview. Therapeutic . Options. Manage Stable COPD. Manage . Exacerbations. . Airway and systemic inflammation. Under-recognized / under-diagnosed. What you should know. !. Todd Tyson, BS, RRT. GAMES Annual Meeting. Jekyll Island. Questions regarding vent . ???. 1. Are you currently accredited to provide ventilators?. 2. Are you Medicare Certified? Does your 855S application include provision for ventilators?. Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. : . Asthma, bronchitis, COPD, emphysema, cystic fibrosis, bronchiectasis, pneumoconiosis, sleep apnea.  . Grandfather developed lymphoma 10 months ago and has responded well to treatment. Since the grandfather’s illness you seem to be seeing more of the family.. Grandmum. ,. It is early September and the kids are back at work and school.. Patient may or may not notice symptoms .. Life expectancy for stage 1 people is only slightly less than the normal people. . It is around 17.4 years for a male who is 65 year old. . Patients who continue smoking will have shorter life than who does not smoke or who stop smoking. . D94- COPD: EPIDEMIOLOGY AND THERAPY. Mini Symposium. Wednesday May 22. Marjan. Kerkhof. 1. , Jaco Voorham. 1. , Claudia Cabrera. 2. , Patrick Darken. 2. , Paul Dorinsky. 2. , . Janwillem. W.H. Kocks. West Suffolk Integrated Formulary . Dr Linda Pearce. Respiratory Consultant Nurse. West Suffolk Hospital NHS Foundation Trust. Declaration . Linda Pearce has undertaken advisory board meetings, lectures and received support to attend educational meetings from. 80 predicted and sometimes but not always Stage II Moderate COPD Worsening airflow limitation FEVbreath typically developing during exertion This is the stage at which patients typically seek medical disease . is characterized by . . airflow limitation that is not fully . reversible.. The . airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases. .